Cargando…
Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development
Matrix metalloproteinases (MMPs) were initially recognised for their extracellular matrix (ECM)-degrading capability during tissue remodelling. Their importance was further highlighted by their role in metastasis. Clinical trials have since evaluated the potential of MMP inhibitors as anticancer the...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394437/ https://www.ncbi.nlm.nih.gov/pubmed/14612884 http://dx.doi.org/10.1038/sj.bjc.6601327 |